Philipp A. Schnabel

11.6k total citations · 2 hit papers
157 papers, 5.5k citations indexed

About

Philipp A. Schnabel is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Philipp A. Schnabel has authored 157 papers receiving a total of 5.5k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Pulmonary and Respiratory Medicine, 48 papers in Oncology and 36 papers in Molecular Biology. Recurrent topics in Philipp A. Schnabel's work include Lung Cancer Treatments and Mutations (41 papers), Lung Cancer Diagnosis and Treatment (28 papers) and Lung Cancer Research Studies (19 papers). Philipp A. Schnabel is often cited by papers focused on Lung Cancer Treatments and Mutations (41 papers), Lung Cancer Diagnosis and Treatment (28 papers) and Lung Cancer Research Studies (19 papers). Philipp A. Schnabel collaborates with scholars based in Germany, United States and Poland. Philipp A. Schnabel's co-authors include Arne Warth, Hans Hoffmann, Thomas Muley, Hendrik Dienemann, Michael Meister, Felix Herth, Peter Schirmacher, Michael Thomas, Wilko Weichert and Albrecht Stenzinger and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Gastroenterology.

In The Last Decade

Philipp A. Schnabel

156 papers receiving 5.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Novel Histologic International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society Classification System of Lung Adenocarcinoma Is a Stage-Independent Predictor of Survival

2012 542 citations Arne Warth, Thomas Muley et al. Journal of Clinical Oncology profile →
Lung cancer mortality reduction by LDCT screening—Results from the randomized German LUSI trial

2019 292 citations Claus Peter Heußel, Hendrik Dienemann et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Philipp A. Schnabel Germany	41	2.6k	1.7k	1.6k	762	694	157	5.5k
Thierry Berghmans Belgium	33	3.2k 1.2×	2.3k 1.3×	1.3k 0.8×	661 0.9×	834 1.2×	181	5.2k
Antonio Llombart‐Bosch Spain	43	3.4k 1.3×	1.8k 1.1×	1.8k 1.1×	1.0k 1.3×	212 0.3×	294	6.7k
Douglas B. Flieder United States	35	2.6k 1.0×	2.0k 1.2×	801 0.5×	555 0.7×	502 0.7×	86	5.2k
Tomoyuki Yokose Japan	43	3.3k 1.3×	2.6k 1.6×	1.2k 0.8×	821 1.1×	702 1.0×	272	6.6k
Rainer Grobholz Germany	39	1.4k 0.5×	910 0.5×	1.8k 1.2×	966 1.3×	506 0.7×	137	4.5k
Ashley E. Winkler United States	10	2.5k 0.9×	3.9k 2.3×	1.1k 0.7×	848 1.1×	751 1.1×	12	7.3k
Ikuo Sekine Japan	38	3.0k 1.2×	3.3k 2.0×	1.3k 0.8×	742 1.0×	379 0.5×	228	5.8k
Lunxu Liu China	38	2.0k 0.8×	1.3k 0.8×	1.5k 1.0×	1.1k 1.4×	356 0.5×	285	4.8k
Kenzo Hiroshima Japan	46	4.4k 1.7×	2.3k 1.4×	1.1k 0.7×	458 0.6×	273 0.4×	292	7.1k
Francesco Mauri Italy	45	963 0.4×	2.0k 1.2×	1.7k 1.1×	892 1.2×	815 1.2×	136	6.2k

Countries citing papers authored by Philipp A. Schnabel

Since Specialization

Citations

This map shows the geographic impact of Philipp A. Schnabel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philipp A. Schnabel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philipp A. Schnabel more than expected).

Fields of papers citing papers by Philipp A. Schnabel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philipp A. Schnabel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philipp A. Schnabel. The network helps show where Philipp A. Schnabel may publish in the future.

Co-authorship network of co-authors of Philipp A. Schnabel

This figure shows the co-authorship network connecting the top 25 collaborators of Philipp A. Schnabel. A scholar is included among the top collaborators of Philipp A. Schnabel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philipp A. Schnabel. Philipp A. Schnabel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Schnabel, Philipp A., Rainer M. Bohle, Rainer Wiewrodt, et al.. (2017). Nontypeable Haemophilus influenzae–Promoted Proliferation of Kras-Induced Early Adenomatous Lesions Is Completely Dependent on Toll-Like Receptor Signaling. American Journal Of Pathology. 187(5). 973–979. 13 indexed citations

Schneider, Marc A., Martin Granzow, Arne Warth, et al.. (2015). Glycodelin: A New Biomarker with Immunomodulatory Functions in Non–Small Cell Lung Cancer. Clinical Cancer Research. 21(15). 3529–3540. 45 indexed citations

Fritzsching, Benedikt, Zhe Zhou-Suckow, Joanna Trojanek, et al.. (2015). Hypoxic Epithelial Necrosis Triggers Neutrophilic Inflammation via IL-1 Receptor Signaling in Cystic Fibrosis Lung Disease. American Journal of Respiratory and Critical Care Medicine. 191(8). 902–913. 81 indexed citations

Rieber, Juliane, Robert Foerster, Marc Bischof, et al.. (2015). Outcome and prognostic factors of postoperative radiation therapy (PORT) after incomplete resection of non-small cell lung cancer (NSCLC). Lung Cancer. 91. 41–47. 5 indexed citations

Kügler, Christian, et al.. (2014). Significance of EGFR expression patterns in patients with non-small cell lung cancer – Evaluation on protein- and/or gene level?. European Respiratory Journal. 44(Suppl 58). P506–P506.

Kristen, Arnt V., Mark Rosenberg, Henning Steen, et al.. (2014). Osteopontin: a novel predictor of survival in patients with systemic light-chain amyloidosis. Amyloid. 21(3). 202–210. 14 indexed citations

Kristen, Arnt V., Katrin Ackermann, Sebastian J. Buss, et al.. (2013). Inhibition of apoptosis by the intrinsic but not the extrinsic apoptotic pathway in myocardial ischemia-reperfusion. Cardiovascular Pathology. 22(4). 280–286. 22 indexed citations

Warth, Arne, Thomas Muley, Michael Meister, et al.. (2012). The Novel Histologic International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society Classification System of Lung Adenocarcinoma Is a Stage-Independent Predictor of Survival. Journal of Clinical Oncology. 30(13). 1438–1446. 542 indexed citations breakdown →

Reinmuth, Niels, Thomas Muley, Hans Hoffmann, et al.. (2012). Characteristics and outcome of patients with second primary lung cancer. European Respiratory Journal. 42(6). 1668–1676. 23 indexed citations

10.

Schnabel, Philipp A., Egbert F. Smit, Javier de Castro, et al.. (2012). Influence of histology and biomarkers on first-line treatment of advanced non-small cell lung cancer in routine care setting: Baseline results of an observational study (FRAME). Lung Cancer. 78(3). 263–269. 16 indexed citations

11.

Warth, Arne, Stephan Macher‐Goeppinger, Thomas Muley, et al.. (2011). Clonality of multifocal nonsmall cell lung cancer: implications for staging and therapy. European Respiratory Journal. 39(6). 1437–1442. 79 indexed citations

12.

Thunnissen, Erik, Keith M. Kerr, Felix Herth, et al.. (2011). The challenge of NSCLC diagnosis and predictive analysis on small samples. Practical approach of a working group. Lung Cancer. 76(1). 1–18. 167 indexed citations

13.

Herpel, Esther, Thomas Muley, Thomas Schneider, et al.. (2010). A Pragmatic Approach to the Diagnosis of Nodal Micrometastases in Early Stage Non-small Cell Lung Cancer. Journal of Thoracic Oncology. 5(8). 1206–1212. 9 indexed citations

14.

Singer, Stephan, Mona Malz, Esther Herpel, et al.. (2009). Coordinated Expression of Stathmin Family Members by Far Upstream Sequence Element-Binding Protein-1 Increases Motility in Non–Small Cell Lung Cancer. Cancer Research. 69(6). 2234–2243. 83 indexed citations

15.

Kristen, Arnt V., Falk‐Udo Sack, Stefan Schönland, et al.. (2009). Staged Heart Transplantation and Chemotherapy as a Treatment Option in Patients with Severe Cardiac Light-Chain Amyloidosis. European Journal of Heart Failure. 11(10). 1014–1020. 37 indexed citations

16.

Kahn, Nicolas, Ruprecht Kuner, Ralf Eberhardt, et al.. (2009). Gene expression analysis of endobronchial epithelial lining fluid in the evaluation of indeterminate pulmonary nodules. Journal of Thoracic and Cardiovascular Surgery. 138(2). 474–479. 12 indexed citations

17.

Koch, Achim, Wilfried Roth, T.J. Dengler, et al.. (2008). Impact of Apoptosis in Acute Rejection Episodes After Heart Transplantation: Immunohistochemical Examination of Right Ventricular Myocardial Biopsies. Transplantation Proceedings. 40(4). 943–946. 7 indexed citations

18.

Kristen, Arnt V., Jolanta B. Perz, Stefan Schönland, et al.. (2007). Non-Invasive Predictors of Survival in Cardiac Amyloidosis. European Journal of Heart Failure. 9(6-7). 617–624. 99 indexed citations

19.

Kristen, Arnt V., F. Joachim Meyer, Jolanta B. Perz, et al.. (2005). Risk Stratification in Cardiac Amyloidosis: Novel Approaches. Transplantation. 80(1S). S151–S155. 19 indexed citations

20.

Rieker, Ralf J., Sebastian Aulmann, Roland Penzel, et al.. (2004). Chromosomal imbalances in sporadic neuroendocrine tumours of the thymus. Cancer Letters. 223(1). 169–174. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact